CaMKK2 is an important component of multiple signalling pathways that regulate glucose metabolism, adipogenesis, nutrient intake, inflammation and bone homoeostasis and has been shown to be deregulated in a number of diseases, such as obesity and cancer [2]. The gene discussed is CAMKK2; the disease is cancer.